Korea Investment Global Frontier Fund

Korea Investment Global Frontier Fund is a prominent venture capital fund managed by Korea Investment Partners (KIP), the leading investment firm in South Korea. The fund specializes in the life sciences, biotechnology, and healthcare sectors, targeting high-growth companies with innovative therapeutic platforms and medical technologies. It focuses on global investment opportunities, bridging the gap between the South Korean biotech market and international hubs in the United States and Europe. By providing significant capital and strategic guidance, the fund supports the development of next-generation modalities such as cell and gene therapies and advanced oncology treatments. Its portfolio includes a diverse range of startups and growth-stage companies aimed at addressing significant unmet medical needs. The fund leverages KIP's extensive global network to facilitate cross-border collaborations and market entry for its portfolio companies.